Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001140361-25-005004
Filing Date
2025-02-18
Accepted
2025-02-18 16:11:01
Documents
8
Period of Report
2025-02-18

Document Format Files

Seq Description Document Type Size
1 FORM 6-K ny20043420x3_6k.htm 6-K 18067
2 EXHIBIT 1.1 ny20043420x3_ex1-1.htm EX-1.1 215175
3 EXHIBIT 4.1 ny20043420x3_ex4-1.htm EX-4.1 69117
4 EXHIBIT 5.1 ny20043420x3_ex5-1.htm EX-5.1 75290
5 EXHIBIT 5.2 ny20043420x3_ex5-2.htm EX-5.2 16278
6 ny20043420x3_ex5-1img01.jpg GRAPHIC 356257
7 ny20043420x3_ex5-2logo01.jpg GRAPHIC 3044
8 ny20043420x3_ex5-2logo02.jpg GRAPHIC 2793
  Complete submission text file 0001140361-25-005004.txt   894014
Mailing Address WINZERLAER STR. 2 JENA 2M 07745
Business Address WINZERLAER STR. 2 JENA 2M 07745 49 3641 508180
InflaRx N.V. (Filer) CIK: 0001708688 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38283 | Film No.: 25634984
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)